We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genomic Study Links Potassium Levels to Regulation of BP

By LabMedica International staff writers
Posted on 04 Jan 2018
A recent paper described a study designed to examine different points of the human genome to determine where the genetic sequence linked serum potassium levels to modulation of blood pressure (BP).

Investigators at the University of Georgia (Athens, USA) performed genome-wide analyses to identify genomic loci that interacted with potassium to influence BP using single-marker and gene-based tests on Chinese participants of the GenSalt study (Genetic Epidemiology Network of Salt Sensitivity).

The initial GenSalt study, which was designed to evaluate gene-diet (sodium and potassium) interactions on BP regulation, was performed in rural areas in northern China from October 2003 to July 2005. More...
The overall objective of the study was to identify susceptibility genes that influenced individual BP responses to dietary sodium and potassium intake in human populations. The specific aims were: (1) To localize and identify novel genes related to variation in BP responses to a low dietary sodium intake and a high dietary sodium intake; (2) To localize and identify novel genes related to variations in BP responses to oral potassium supplementation; and (3) To localize and identify novel genes related to BP responses to a cold pressor test. In addition, the GenSalt study localized and identified genes related to usual BP level and the risk of hypertension.

For the current study, the investigators analyzed data from1876 GenSalt participants. The average results of three urine samples were used to estimate potassium excretion, while nine BP measurements were taken using a random-zero sphygmomanometer. A total of 2.2 million single nucleotide polymorphisms were imputed using Affymetrix (Santa Clara, CA, USA) 6.0 genotype data and the Chinese Han of Beijing and Japanese of Tokyo HapMap reference panels.

Results published in the December 6, 2017, online edition of the journal Circulation: Cardiovascular Genetics revealed two genomic loci - one of which had never been identified - and six individual genes, all significantly associated with the regulation of blood pressure in the body.

“One of the major drawbacks of previous genetic studies of hypertension is that these studies did not explore the interactions between genes and environmental factors,” said senior author Dr. Changwei Li, assistant professor of biostatistics and epidemiology at the University of Georgia. “For example, some genes’ effect on blood pressure only manifests under certain environments. If environmental factors are not taken into account, these genes will not be identified for hypertension.”

“Findings from our study help to identify individuals who are particularly sensitive to dietary potassium as a way to reduce blood pressure, based on their genomic profiles,” said Dr. Li. “Subsequently, we could provide personalized suggestions to prevent disease based on their genotypes.”

Related Links:
University of Georgia
Affymetrix


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.